Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMZON3T)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
(S)-pyrrolidin-2-ylmethanamine; 69500-64-7; (S)-(+)-2-(Aminomethyl)pyrrolidine; (2S)-PYRROLIDIN-2-YLMETHYLAMINE; (S)-2-(Aminomethyl)pyrrolidine; (S)-2-aminomethylpyrrolidine; (S)-pyrrolidin-2-ylmethylamine; [(2S)-pyrrolidin-2-yl]methanamine; 1-[(2S)-pyrrolidin-2-yl]methanamine; 2-Pyrrolidinemethanamine, (2S)-; (S)-(+)-2-(Aminomethyl)pyrrolidine, 98%; AC1MC09B; SCHEMBL83314; CHEBI:44632; CTK5D0186; (2S)-pyrrolidin-2-ylmethanamine; MolPort-003-932-494; AUKXFNABVHIUAC-YFKPBYRVSA-N; (2S)-Pyrrolidin-2-yl-methylamine; ZINC39357503
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||